We recently published a list of 10 Stocks Analysts are Talking About Amid Trump’s Tariff War. In this article, we are going ...

With an FDA review underway, Johnson & Johnson is aiming to “fundamentally change” how bladder cancer is treated. | With an ...

Johnson & Johnson, one of the few remaining companies with a top credit rating, is no longer at risk of a downgrade, S&P ...